logo

Neurogene Inc (NGNE) Stock: Exploring a Year of Highs, Lows, and Trading Volume

ELVT Stock

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Neurogene Inc’s current trading price is -73.39% away from its 52-week high, while its distance from the 52-week low is 58.69%. The stock’s price range during this period has varied between $12.49 and $74.49. The company, active in the Healthcare sector, saw a trading volume of around 2.0 million for the day, considerably higher average daily volume of 0.18 million observed over the last three months.

Neurogene Inc’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $74.49 on 11/11/24, with the lowest value being $12.49 on 12/20/23.

How Financial Performance Impacts Market Capitalization

Neurogene Inc (NGNE) has experienced a quarterly decline of -44.48% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 226.75M and boasts a workforce of 91 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 42.48, with a change in price of -15.00. Similarly, Neurogene Inc recorded 195,953 in trading volume during the last 100 days, posting a change of -43.08%.

How NGNE’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for NGNE stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.07.

NGNE Stock Stochastic Average

As of today, the raw stochastic average of Neurogene Inc over the last 50 days is at 1.58%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 1.58%. Further, the company’s Stochastic %K and %D values for the last 20 days were 7.09% and 9.26%, respectively.

NGNE Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price gain of 2.27% this year. Over the last six months, there has been a stronger performance of -41.72%. The price of NGNE leaped by -63.57% during the last 30 days period. For the last 5-days stocks have slided -72.29%.

Most Popular